Published in Case Rep Infect Dis on August 15, 2016
Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis (1992) 2.78
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis (1999) 2.69
Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis (2003) 2.54
Human infections due to Streptococcus dysgalactiae subspecies equisimilis. Clin Infect Dis (2009) 1.91
Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy. Clin Infect Dis (1998) 1.83
Fatal case of toxic shock-like syndrome due to group C streptococcus associated with superantigen exotoxin. J Clin Microbiol (2004) 1.29
Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA (1992) 1.23
Necrotising fasciitis. Lancet (1994) 1.22
T cell activation and cytokine release in streptococcal toxic shock-like syndrome. J Pediatr (1993) 1.03
Invasive Group C Streptococcus infection associated with rhabdomyolysis and disseminated intravascular coagulation in a previously healthy adult. Scand J Infect Dis (2001) 0.99
Toxic shock syndrome due to group C streptococci. A case report. Intensive Care Med (1996) 0.98
Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review. Clin Infect Dis (1995) 0.89